Peripherial Venous PressureNCT05476666
Peripheral Venous Pressure as an Indicator of Central Venous Pressure in Post Operative Surgical Patients: A Randomised Controlled Trial
A study testing Peripherial and central venous access in people with Peripherial Venous Pressure and Central Venous Pressure, run by Pakistan Navy Station Shifa Hospital at 1 site in Pakistan.
Trial summary
The study is aimed at comparing peripherial venous pressure as an indicator of central venous pressure in post operative surgical patients. Read more about this study
- Who is it for?
- Ages 18 to 75 years
- Conditions the study is for
- Peripherial Venous Pressure, Central Venous Pressure, Fluid/Volume Status Monitoring of Patient
- What is being tested?
- Peripherial and central venous access
- Type of treatment
- Surgery or procedure
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 sitePakistan
- Study dates
- 1 Mar 2022to 15 Jun 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 75 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- ASA I/II/III surgical patients who require central venous access as part of their surgical treatment plan with no organ support in post operative period.
- Age between 18 and 75 years
- Who have atleast 1 x 18 gauge peripherial venous cannula in the upper limb from elbow below to the hand
- Who have given consent
Who cannot join
- Not meeting the inclusion criteria
Trial locations and contacts
1 site in 1 country.
About this study
The study is aimed at comparing peripherial venous pressure as an indicator of central venous pressure in post operative surgical patients.
- Conditions
- Peripherial Venous Pressure, Central Venous Pressure, Fluid/Volume Status Monitoring of Patient
- Being tested
- Peripherial and central venous access
- Keywords
- Peripherial venous pressure, Central venous pressure
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Peripherial and central venous accessProcedure or surgery
Passing a peripherial and a central venous catheter/cannula
| Study group | Role | What they receive |
|---|---|---|
| Pressures measured | Experimental | Venous pressure measured through a peripherial and a central venous catheter/cannula Receives: Procedure: Peripherial and central venous access |
What is being measured
The primary outcome is the main question the study is designed to answer.
Peripherial venous pressure as an indicator of central venous pressure
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted27 Jul 2022
- Study start1 Mar 2022
- Primary completion31 May 2022
- Study completion15 Jun 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Peripherial Venous PressureStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (actual)
Sponsor and investigators
- Lead sponsor
- Pakistan Navy Station Shifa Hospital
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Kenan Anwar Khan, Pakistan Navy Station Shifa Hospital
- Investigators
- Kenan Khan, Principal investigator, Pakistan Navy Station Shifa Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05476666
- Sponsor's protocol ID
- ERC/2022/ANS/1
- Status last verified
- Aug 2022
- First submitted
- 25 Jul 2022
- Last updated
- 3 Aug 2022
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Aug 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Peripheral Venous Pressure as an Indicator of Central Venous Pressure in Post Operative Surgical Patients: A Randomised Controlled Trial
- ClinicalTrials.gov ID
- NCT05476666
- Acronym / sponsor ID
- ERC/2022/ANS/1
- Conditions
- Peripherial Venous Pressure, Central Venous Pressure, Fluid/Volume Status Monitoring of Patient
- Keywords
- Peripherial venous pressure, Central venous pressure
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 40 participants (actual)
- Lead sponsor
- Pakistan Navy Station Shifa HospitalUniversity, hospital or other
- Study start
- 1 Mar 2022 (actual)
- Primary completion
- 31 May 2022 (actual)
- Study completion
- 15 Jun 2022 (actual)
- First posted
- 27 Jul 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The study is aimed at comparing peripherial venous pressure as an indicator of central venous pressure in post operative surgical patients.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pressures measured | Experimental | Procedure: Peripherial and central venous accessVenous pressure measured through a peripherial and a central venous catheter/cannula |
Who may qualify
- Ages
- 18 to 75 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- ASA I/II/III surgical patients who require central venous access as part of their surgical treatment plan with no organ support in post operative period.
- Age between 18 and 75 years
- Who have atleast 1 x 18 gauge peripherial venous cannula in the upper limb from elbow below to the hand
- Who have given consent
Key exclusion criteria (1 listed)
- Not meeting the inclusion criteria
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Peripherial and central venous accessPassing a peripherial and a central venous catheter/cannula | Procedure or surgery | Pressures measured |
Primary outcome
Peripherial venous pressure as an indicator of central venous pressure
Time frame: 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Aug 2022.
- Individual participant dataSharing planned: No
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Kenan Khan principal investigator
Pakistan Navy Station Shifa Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Peripherial and central venous access in people with Peripherial Venous Pressure and Central Venous Pressure, run by Pakistan Navy Station Shifa Hospital at 1 site in Pakistan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 3 Aug 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Peripherial venous pressure as an indicator of central venous pressure (time frame: 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2022.